CD19 and Miyoshi myopathy: Flow cytometry analysis was applied to characterize the BM‐derived CD19+CD24hiCD38hi Bregs in the elderly MM and data were available in 32 patients (Figure 4A and Table S1), including 15 receiving Bd regimen, two receiving BCd regimen, and six receiving BRd regimen.